| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/01/1997 | US5616688 Macrophage-derived inflammatory mediator (MIP-1α and MIP-1β) |
| 04/01/1997 | US5616561 TGF-β antagonists as mitigators of radiation-induced tissue damage |
| 04/01/1997 | US5616492 Monoclonal antibodies differentially reactive with native and reductively modified Bowman-Birk protease inhibitor |
| 04/01/1997 | US5616481 Genetic engineered dna technology in neurobiology |
| 04/01/1997 | US5616472 Process for producing monoclonal antibodies against human T cell receptor elements using recombinant DNA vectors, and cells transfected thereby |
| 04/01/1997 | US5616470 Monoclonal antibodies to white pine blister rust fungus Cronartium ribicola |
| 04/01/1997 | US5616468 Compositions and diagnostic methods using monoclonal antibodies against CD44v6 |
| 04/01/1997 | US5616463 Stimulating cells with ionizing radiation, comparing level of gadd45 messenger rna in stimulated cells to that in unstimulated cells |
| 04/01/1997 | US5616322 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope |
| 04/01/1997 | US5616321 Method of treating bacterial meningitis with anti-tumor necrosis factor antibody |
| 04/01/1997 | US5616298 Test kit for detecting analyte in sample |
| 04/01/1997 | US5616122 Methods and compositions for preventing secondary cataracts |
| 03/27/1997 | WO1997011370A1 Recombinant proteins having multiple disulfide bonds and thiol-substituted conjugates thereof |
| 03/27/1997 | WO1997011200A1 Human herpesvirus type 8 isolated from human lymphoma cell line and uses thereof |
| 03/27/1997 | WO1997011188A1 Plants which synthesise a modified starch, process for the production thereof and modified starch |
| 03/27/1997 | WO1997011177A1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 03/27/1997 | WO1997011093A2 Parainfluenza virus glycoproteins and vaccines |
| 03/27/1997 | WO1997010847A1 Targeting of conjugates of poly(ethylene glycol) and antibodies against glutamic acid decarboxylase to islet cells |
| 03/27/1997 | WO1997010846A1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 03/27/1997 | WO1997010796A2 MANIPULATION AND DETECTION OF PROTEIN PHOSPHATASE 2C - PP2Cα - EXPRESSION IN TUMOR CELLS FOR CANCER THERAPY, PREVENTION AND DETECTION |
| 03/27/1997 | WO1997005253A3 Transketolase-related protein |
| 03/27/1997 | WO1997000088A3 Rotavirus enterotoxin nsp4 and methods of using same |
| 03/27/1997 | WO1996029974A3 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 03/27/1997 | CA2232834A1 Targeting of conjugates of poly(ethylene glycol) and antibodies against glutamic acid decarboxylase to islet cells |
| 03/27/1997 | CA2232601A1 Recombinant proteins having multiple disulfide bonds and thiol-substituted conjugates thereof |
| 03/27/1997 | CA2232515A1 Parainfluenza virus glycoproteins and vaccines |
| 03/27/1997 | CA2230127A1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 03/27/1997 | CA2230116A1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 03/27/1997 | CA2227306A1 Manipulation and detection of protein phosphatase 2c - pp2c.alpha. - expression in tumor cells for cancer therapy, prevention and detection |
| 03/26/1997 | EP0764849A1 Immunological ELISA test for intra-alpha-trypsin inhibitor |
| 03/26/1997 | EP0764721A1 ATP-sensitive potassium-channel proteins and genes for the same |
| 03/26/1997 | EP0764658A1 Process for obtaining immunoglobulins from fractions originating from the fractionation of human blood plasma |
| 03/26/1997 | EP0764657A1 Diagnostic and therapeutic compositions and methods for lipoprotein(a) |
| 03/26/1997 | EP0764447A2 Preparation of virally inactivated intravenously injectable immune serum globulin |
| 03/26/1997 | EP0764273A1 Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis |
| 03/26/1997 | EP0764203A1 Methods for selectively stimulating proliferation of t cells |
| 03/26/1997 | EP0764171A1 Ligands for induction of antigen specific apoptosis in t cells |
| 03/26/1997 | EP0764048A1 Chromatography adsorbents utilizing mercapto heterocyclic ligands |
| 03/26/1997 | EP0764030A1 Use of autoantibodies for tumor therapy and prophylaxis |
| 03/26/1997 | EP0585217B1 Preparation exhibiting enzymatic delignification activity, a method of producing the same, and applications thereof |
| 03/26/1997 | CN1146157A Fibrin-specific antibody for use as an antithrombrotic agent |
| 03/26/1997 | CN1145953A DNA Sequence Coding for protein of A. thaliana having delta-5,7 terol, delta-7 reductase activity, delta T-red protein, production process strains of transformed yeasts uses |
| 03/26/1997 | CN1145909A Anti-ganglioside monoclonal antibodies and their use in specific active immunotherapy of malignant tumors |
| 03/25/1997 | US5614620 DNA binding proteins including androgen receptor |
| 03/25/1997 | US5614611 Humanized monoclonal antibodies binding to IgE-bearing B cells but not basophils |
| 03/25/1997 | US5614610 Tumor immunotherapy using anti-idiotypic antibodies |
| 03/25/1997 | US5614609 Serine threonine kinase receptor |
| 03/25/1997 | US5614500 Compositions containing highly purified factor IX proteins prepared by immunoaffinity chromatography |
| 03/25/1997 | US5614488 Cytoxic fragment of a peptide toxin |
| 03/25/1997 | US5614419 Reagents and methods for the quantification of amitriptyline or nortriptyline in biological fluids |
| 03/25/1997 | US5614409 Production of IBDV VP2 in highly immunogenic form |
| 03/25/1997 | US5614408 From hybridoma cell line |
| 03/25/1997 | US5614406 Kainate-binding human CNS receptors of the EAA2 family |
| 03/25/1997 | US5614394 Immunizing mice, fusion of lymphocytes and myeloma cells |
| 03/25/1997 | US5614385 Morphogens |
| 03/25/1997 | US5614373 Tumor-specific antibodies and antigen |
| 03/25/1997 | US5614372 Distiction between cancer and benign hyperplasia |
| 03/25/1997 | US5614367 Diagnostic test using chimeric antibodies |
| 03/25/1997 | US5614366 HTLV-I peptide antigens and kit |
| 03/25/1997 | US5614195 Coccidiosis poultry vaccine |
| 03/25/1997 | US5614194 Protective peptide antigen |
| 03/25/1997 | US5614192 T cell receptor peptides as therapeutics for immune-related disease |
| 03/25/1997 | US5614191 Antitumor |
| 03/25/1997 | US5614187 Conferring tolerance to foreign tissue in recipient mammal |
| 03/25/1997 | CA2050479C Cd3 specific recombinant antibody |
| 03/25/1997 | CA1339027C Synthetic peptides, antibodies directed against them, and the use thereof |
| 03/25/1997 | CA1339015C Macrocyclic chelates and methods of use thereof |
| 03/25/1997 | CA1339014C Antibodies to a4 amyloid peptide |
| 03/25/1997 | CA1339013C Cross-protective human monoclonal antibody compositions |
| 03/23/1997 | CA2185617A1 Method for recovering immunoglobulin from fractions produced during fractionation of human blood plasma |
| 03/20/1997 | WO1997010505A1 ANTIBODIES SPECIFIC FOR NATIVE PrP?Sc¿ |
| 03/20/1997 | WO1997010504A1 Antibody radioimmunoassays for human propeptide/prohormone convertases pc1/3 and pc2 |
| 03/20/1997 | WO1997010354A1 ANTIBODY AGAINTS α-CHAIN OF HUMAN INTERLEUKIN 5 RECEPTOR |
| 03/20/1997 | WO1997010351A1 Exopolysaccharides of burkholderia pseudomallei and burkholderia mallei |
| 03/20/1997 | WO1997010336A1 A kinase anchoring protein and uses thereof |
| 03/20/1997 | WO1997010258A2 Antibodies against epitopes, exposed on surfaces of cancer cells outside desmosomes, of desmosomal cadherines |
| 03/20/1997 | WO1997010252A1 Dna encoding an sh2-inositol phosphatase, an shc-binding protein |
| 03/20/1997 | WO1997010249A1 Toxoplasma gondii glycoconjugates |
| 03/20/1997 | WO1997010004A1 Methods for treatment of interstitial cystitis |
| 03/20/1997 | WO1997010003A1 Methods and compositions comprising single chain recombinant antibodies |
| 03/20/1997 | WO1997000952A3 A human edg-2 receptor homolog |
| 03/20/1997 | WO1997000892A3 Depigmenting activity of agouti signal protein and peptides thereof |
| 03/20/1997 | DE19534630A1 Monoclonal antibodies to epithelial mucin |
| 03/20/1997 | DE19534195A1 Agent for enhancing binding properties of auto-antibodies |
| 03/20/1997 | CA2232012A1 Toxoplasma gondii glycoconjugates |
| 03/19/1997 | EP0763601A2 Homogeneous hybridization assay with label specific receptors |
| 03/19/1997 | EP0763543A2 A method for preparing an inflammatory cytokine (MIP-2) and diagnostic and therapeutic applications for the cytokine or its antibody |
| 03/19/1997 | EP0763131A1 Toxin assay |
| 03/19/1997 | EP0763128A1 Method for producing heterologous bispecific antibodies |
| 03/19/1997 | EP0763114A2 Hepatitis g virus and molecular cloning thereof |
| 03/19/1997 | EP0763110A2 Mn gene and protein |
| 03/19/1997 | EP0763109A1 Factor interacting with nuclear proteins |
| 03/19/1997 | EP0763104A1 Human dna topoisomerase i-alpha |
| 03/19/1997 | EP0763101A1 Nucleic acid sequences and expression systems for heparinase ii and heparinase iii derived from flavobacterium heparinum |
| 03/19/1997 | EP0763100A1 Method of purification of clostridium difficile toxin a and production of mono-specific antibodies |
| 03/19/1997 | EP0763058A1 $i(RPS) GENE FAMILY, PRIMERS, PROBES, AND DETECTION METHODS |
| 03/19/1997 | EP0763046A1 Dna encoding gls1 |
| 03/19/1997 | EP0763045A1 Haemopoietic maturation factor |
| 03/19/1997 | EP0762892A1 Diphtheria toxin vaccines bearing a mutated r domain |
| 03/19/1997 | EP0762885A1 Glial mitogenic factors, their preparation and use |